Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157


Differential modulation of human melanoma cell metalloproteinase expression by alpha2beta1 integrin and CD44 triple-helical ligands derived from type IV collagen.

Baronas-Lowell D, Lauer-Fields JL, Borgia JA, Sferrazza GF, Al-Ghoul M, Minond D, Fields GB.

J Biol Chem. 2004 Oct 15;279(42):43503-13. Epub 2004 Aug 2.


Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation.

Lauer-Fields JL, Malkar NB, Richet G, Drauz K, Fields GB.

J Biol Chem. 2003 Apr 18;278(16):14321-30. Epub 2003 Feb 6.


Modulation of triple-helical stability and subsequent melanoma cellular responses by single-site substitution of fluoroproline derivatives.

Malkar NB, Lauer-Fields JL, Borgia JA, Fields GB.

Biochemistry. 2002 May 14;41(19):6054-64.


Induction of endothelial cell activation by a triple helical alpha2beta integrin ligand, derived from type I collagen alpha1(I)496-507.

Baronas-Lowell D, Lauer-Fields JL, Fields GB.

J Biol Chem. 2004 Jan 9;279(2):952-62. Epub 2003 Oct 26.


Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.

Shahan TA, Ziaie Z, Pasco S, Fawzi A, Bellon G, Monboisse JC, Kefalides NA.

Cancer Res. 1999 Sep 15;59(18):4584-90.


Selective binding of integrins from different renal cell types to the NC1 domain of alpha3 and alpha1 chains of type IV collagen.

Aggeli AS, Kitsiou PV, Tzinia AK, Boutaud A, Hudson BG, Tsilibary EC.

J Nephrol. 2009 Jan-Feb;22(1):130-6.


The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix.

Käpylä J, Jäälinoja J, Tulla M, Ylöstalo J, Nissinen L, Viitasalo T, Vehviläinen P, Marjomäki V, Nykvist P, Säämänen AM, Farndale RW, Birk DE, Ala-Kokko L, Heino J.

J Biol Chem. 2004 Dec 3;279(49):51677-87. Epub 2004 Sep 21.


A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells.

Pasco S, Han J, Gillery P, Bellon G, Maquart FX, Borel JP, Kefalides NA, Monboisse JC.

Cancer Res. 2000 Jan 15;60(2):467-73.


Melanoma cell adhesion and spreading activities of a synthetic 124-residue triple-helical "mini-collagen".

Fields CG, Mickelson DJ, Drake SL, McCarthy JB, Fields GB.

J Biol Chem. 1993 Jul 5;268(19):14153-60.


A peptide model of basement membrane collagen alpha 1 (IV) 531-543 binds the alpha 3 beta 1 integrin.

Miles AJ, Knutson JR, Skubitz AP, Furcht LT, McCarthy JB, Fields GB.

J Biol Chem. 1995 Dec 8;270(49):29047-50.


Inhibition of melanoma cell binding to type IV collagen by analogs of cell adhesion regulator.

Lauer JL, Furcht LT, Fields GB.

J Med Chem. 1997 Sep 12;40(19):3077-84.


The integrin alpha1 A-domain is a ligand binding site for collagens and laminin.

Calderwood DA, Tuckwell DS, Eble J, Kühn K, Humphries MJ.

J Biol Chem. 1997 May 9;272(19):12311-7.


New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

Petitclerc E, Boutaud A, Prestayko A, Xu J, Sado Y, Ninomiya Y, Sarras MP Jr, Hudson BG, Brooks PC.

J Biol Chem. 2000 Mar 17;275(11):8051-61.

Supplemental Content

Support Center